145 related articles for article (PubMed ID: 19383751)
1. Does the FDA have the authority to trump the Declaration of Helsinki?
Goodyear MD; Lemmens T; Sprumont D; Tangwa G
BMJ; 2009 Apr; 338():b1559. PubMed ID: 19383751
[No Abstract] [Full Text] [Related]
2. Trials on trial.
Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
[No Abstract] [Full Text] [Related]
3. Another meeting on the Helsinki Declaration.
Bull Med Ethics; 2001 Mar; (166):13-4. PubMed ID: 11878333
[No Abstract] [Full Text] [Related]
4. Ethics. Clinical trials guidelines at odds with U.S. policy.
Normile D
Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
[No Abstract] [Full Text] [Related]
5. FDA uneasy about placebo revision.
Hollon T
Nat Med; 2001 Jan; 7(1):7. PubMed ID: 11135592
[No Abstract] [Full Text] [Related]
6. Helsinki discords: FDA, ethics, and international drug trials.
Kimmelman J; Weijer C; Meslin EM
Lancet; 2009 Jan; 373(9657):13-4. PubMed ID: 19121708
[No Abstract] [Full Text] [Related]
7. Helsinki Declaration revisions.
Schuklenk U
Issues Med Ethics; 2001; 9(1):29. PubMed ID: 16334459
[No Abstract] [Full Text] [Related]
8. The monopoly stage of capitalism.
Nicholson RH
Hastings Cent Rep; 2001; 31(3):8. PubMed ID: 11478126
[No Abstract] [Full Text] [Related]
9. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
[TBL] [Abstract][Full Text] [Related]
10. Globalized clinical trials and informed consent.
Annas GJ
N Engl J Med; 2009 May; 360(20):2050-3. PubMed ID: 19439740
[No Abstract] [Full Text] [Related]
11. Declaration of Helsinki should be strengthened.
Rothman KJ
BMJ; 2000 Aug; 321(7258):442-5. PubMed ID: 10938059
[No Abstract] [Full Text] [Related]
12. The FDA and Helsinki.
Rennie S
Hastings Cent Rep; 2009; 39(3):49. PubMed ID: 19537622
[No Abstract] [Full Text] [Related]
13. Ethical issues in the design and conduct of clinical trials in developing countries.
Shapiro HT; Meslin EM
N Engl J Med; 2001 Jul; 345(2):139-42. PubMed ID: 11450665
[No Abstract] [Full Text] [Related]
14. The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations.
Zion D; Gillam L; Loff B
Nat Med; 2000 Jun; 6(6):615-7. PubMed ID: 10835665
[No Abstract] [Full Text] [Related]
15. Ethical and scientific implications of the globalization of clinical research.
Andrews CA
N Engl J Med; 2009 Jun; 360(26):2793; author reply 2793. PubMed ID: 19557890
[No Abstract] [Full Text] [Related]
16. [Take-over of the risk-benefit by the clinical study subject and its regulation].
Antal J
Orv Hetil; 2005 Jun; 146(26):1399-404. PubMed ID: 16052982
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
18. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Lachin JM
Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
[TBL] [Abstract][Full Text] [Related]
19. Playing safe and preserving integrity: making the FDA model work.
Wittes J
Stat Med; 2004 May; 23(10):1523-5. PubMed ID: 15122731
[TBL] [Abstract][Full Text] [Related]
20. Should the Declaration of Helsinki be revised?
Morens DM
N Engl J Med; 1999 Dec; 341(24):1851; author reply 1853. PubMed ID: 10610458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
